Good morning, everyone, and nice to see you again. Yet another deep freeze has descended on the Pharmalot corporate campus, but we manage to keep warm with our mandatory cup of stimulation and stimulating news. On that note, we offer you a smattering of tidbits to get you started. We hope your day goes well and your goals are accomplished. Have a good one...
Novartis Moves To Prevent Execution Drug From Reaching US (Reuters)
Botox Use For Migraines Is Questioned (BBC News)
Novartis And Pfizer Drugs Boost Lung Function In COPD Patients (Reuters)
Medical Device Makers Shun The US (New York Times)
J&J Negotiates Hip Replacements With Lawyers (Bloomberg News)
Black Rock To Provide Data Merck Wants For Vytorin Defense (Dow Jones)
Shire Pharma Earnings Match Expectations (Reuters)
IFPMA Supports Extending TRIPS Deadline (Pharma Times)
Merck's Fosamax Didn't Cause Jaw Damage, Lawyer Argues (Bloomberg News)
China Pre-Clinical Growth Slower Than Expected (Outsourcing Pharma)